Product Classification
| Catalog No. | Product Name | Specification |
| MH000-N011 | MSC Serum-free Medium MH01 | 500ml |
| MH000-N012 | MSC Serum-free Medium MH01 | 1000ml |
Product Overview
The MSC Serum-free Medium MH01 is a serum-free, xeno-free medium specifically optimized for the isolation and expansion of human mesenchymal stem cells (hMSCs) under fully serum-free, phenol red-free, and xeno-free conditions. It supports primary MSC isolation using explant and enzymatic digestion methods and enables expansion over multiple passages, preserving the stability of cell surface markers.
● Serum-free, xeno-free.
● High primary yield: 10⁶–10⁷ cells from a 15 cm umbilical cord in 14 days.
● High expansion: uniform morphology, 6–10x fold expansion in 72 hours, stable for 20 passages.
● Ready-to-use: retains multilineage differentiation potential and CD markers.
● Independently developed, stable supply, GMP.
Specifications & Data
Fig1. A statistical graph of the MSC expansion fold during passage culture, tested over 20 continuous passages using MH01 and a competitor product. The sample consisted of cryopreserved umbilical cord cells, passaged at a density of 10,000 cells/cm², with a passage time of 72 hours. |
Fig2. A statistical graph of the MSC doubling time during passage culture, tested over 20 continuous passages using MH01 and a competitor product. The sample consisted of cryopreserved umbilical cord cells, passaged at a density of 10,000 cells/cm², with a passage time of 72 hours. |
Fig3. A statistical graph showing the change in cell diameter of MSCs during passage culture, tested over 20 continuous passages using MH01 and a competitor product. The sample consisted of cryopreserved umbilical cord cells, passaged at a density of 10,000 cells/cm², with a passage time of 72 hours. |
Fig 4. Representative images of MSCs during continuous 12-passage culture, tested using MH01. The sample consisted of cryopreserved umbilical cord cells, passaged at a density of 10,000 cells/cm², with a passage time of 72 hours. |
Fig 5.Representative flow cytometry images of MSCs at passage 5 (P5), tested using MH01. The sample consisted of cryopreserved umbilical cord cells, passaged at a density of 10,000 cells/cm², with a passage time of 72 hours. |
Fig 6. Immunosuppressive ability test of MSCs at passage 8 (P8), using MH01. The comparison was made between culture media containing 5% FBS and 5% hPL. |
Documents
Manual_MHN01X
MSDS_MHN01X
Application
Gene therapy refers to a medical intervention that modifies or replaces defective genes within an individual's cells to treat or prevent diseases. ExCell Bio has developed series of products，services to support your research.
ExCell Bio has built an advanced culture media factory with large-scale, informationization and internationalization. We can provide international-leading high-performance and high-quality classical cell culture Fetal bovin serum. We can provide different
The therapeutic use of stem cells as potential therapies for a variety of diseases has been widely explored, and the number of clinical trials conducted using mesenchymal stem cells has grown exponentially in the past few years.
In the field of immunocyte therapy Excell Bio provides you with end-to-end solutions to help you develop therapies that can save lives. Our mission is to build Bridges to help you reach your next milestone, to help you progress, and to drive yourimmunocy
RELATED PRODUCTS
